Picture of Akoya Biosciences logo

AKYA — Akoya Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Akoya Biosciences Inc reports results for the quarter ended in January - Earnings Summary

* Akoya Biosciences Inc  AKYA.OQ  reported a quarterly
adjusted
loss of 48 cents​​ per share for the quarter ended in January,
higher than the same quarter last year, when the company
reported EPS of -49 cents.  The mean expectation of
eight analysts for the quarter was for a loss of 29 cents per
share. Wall Street expected results to range from -32 cents
to -26 cents per share.
    * Revenue fell 14.3% to $18.35 million from a year ago;
analysts
expected $24.28 million. 
    * Akoya Biosciences Inc's reported EPS for the quarter was a
loss
of 48 cents​.
    * The company reported a quarterly loss of $23.48 million.
    * Akoya Biosciences Inc shares had fallen by 9.1% this
quarter and
lost 12.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 12.3%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Akoya Biosciences
Inc is $8.50 
This summary was machine generated from LSEG data May 13 at
09:22 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.29          -0.48          Missed
 Dec. 31 2023      -0.27          -0.22          Beat
 Sep. 30 2023      -0.37          -0.26          Beat
 Jun. 30 2023      -0.44          -0.46          Missed

Recent news on Akoya Biosciences

See all news